Live from the NIH registry
Studies recruiting near Killeen right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Heart Failure (HF)
N/A
Interventional 420 participants sought
Baylor Scott & White Research Institute — Temple, Texas (22.9 mi)
· Sponsor: Aventusoft, LLC.
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
C3G
Phase 3
Interventional 98 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
Traumatic Injury, PTSD
N/A
Interventional 300 participants sought
Baylor Scott & White Medical Center - Temple — Temple, Texas (22.9 mi)
· Sponsor: Baylor Research Institute
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: NRG Oncology
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 2
Interventional 111 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
Stress Disorders, Post-Traumatic
Phase 2
Interventional 140 participants sought
Carl R. Darnall Army Medical Center — Fort Hood, Texas (12.5 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Heart Failure NYHA Class II, Heart Failure NYHA Class III
N/A
Interventional 1,750 participants sought
Baylor - Temple — Temple, Texas (22.9 mi)
· Sponsor: Endotronix, Inc.
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Baylor Scott & White - Temple — Temple, Texas (22.9 mi)
· Sponsor: Alleviant Medical, Inc.
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
Basal Ganglia Intracerebral Hemorrhage
N/A
Interventional 300 participants sought
Baylor Scott & White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Weill Medical College of Cornell University
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 130 participants sought
Baylor Scott & White Health — Temple, Texas (22.9 mi)
· Sponsor: Hoffmann-La Roche
I-DECIDE After Bronchiolitis Hospitalization
Bronchiolitis Acute
N/A
Interventional 2,700 participants sought
Baylor Scott and White Mclane Children's — Belton, Texas (15.8 mi)
· Sponsor: Seattle Children's Hospital
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
Anger Problems, Aggression
N/A
Interventional 40 participants sought
Carl R. Darnall Army Medical Center (CRDAMC) at Fort Cavazos — Fort Cavazos, Texas (4.9 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Scott And White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
CLL, Chronic Lymphocytic Leukemia
Phase 3
Interventional 250 participants sought
Baylor Scott and White Health — Temple, Texas (22.9 mi)
· Sponsor: BeOne Medicines
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
GMG Clinical Research, LLC dba Radiance Clinical Research — Lampasas, Texas (26.8 mi)
· Sponsor: Kallyope Inc.
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Cancer Harboring BRAF Alterations, HGG
Phase 2
Interventional 254 participants sought
Baylor Scott & White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Fore Biotherapeutics
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Temple, Texas (22.9 mi)
· Sponsor: AstraZeneca
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Baylor Scott and White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Hoffmann-La Roche
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2
Interventional 160 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Baylor Scott and White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Relay Therapeutics, Inc.